Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Ph…
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of Corvus Pharmaceuticals, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| HOOKIPA Pharma Inc. | FMP | High | United States | New York | |
| X4 Pharmaceuticals, Inc. | FMP | High | United States | Boston | |
| Inozyme Pharma, Inc. | FMP | High | United States | Boston | |
| Terns Pharmaceuticals, Inc. | FMP | High | United States | Foster City | |
| Acumen Pharmaceuticals, Inc. | FMP | High | United States | Charlottesville | |
| PDS Biotechnology Corporation | FMP | High | United States | Florham Park | |
| Day One Biopharmaceuticals, Inc. | FMP | High | United States | South San Francisco |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |